Skip to content
中文产业新闻评分62Chinese source

默沙东帕博利珠单抗皮下注射剂(MK-3475A)获 NMPA 批准,成国内首个 PD-1 单抗皮下注射剂

国内首个!默沙东 K 药皮下注射剂获批上市

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.